The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Open accessAbstract
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures from tumors that represent the greatest unmet need: endocrine-resistant, treatment-refractory and metastatic breast cancers. We leverage matched PDXs and PDX-derived organoids (PDxO) for drug screening that is feasible and cost-effective with in vivo validation. Moreover, we demonstrate the feasibility of using these models for precision oncology in real time with clinical care in a case of triple-negative breast cancer (TNBC) with early metastatic recurrence. Our results uncovered a Food and Drug Administration (FDA)-approved drug with high efficacy against the models. Treatment with this therapy resulted in a complete response for the individual and a progression-free survival (PFS) period more than three times longer than their previous therapies. This work provides valuable methods and resources for functional precision medicine and drug development for human breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“They found that benign organoids carrying mutations in 1–2 genes could not form tumors while more malignant ones with mutations in 4–5 genes were tumorigenic173.”
From Organoids (2022) · cites this paper as [173]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Self-citationRobinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,037
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Research works printed but not linked: 2
- Bruna, A. et al. A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds. Cell 167, 260–274 (2016). · DOI
- Carlson J. A., Garg R., Compton S. R., Zeiss C., & Uchio E. Poliomyelitis in SCID mice following injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus. In Proc. 59th AALAS National Meeting 9–13 (AALAS, 2008).
Cited by
Sorted by citations
Items 101–200 of 420
Mukhopadhyay, D., Goel, H. L., Xiong, C., Goel, S., Kumar, A., Li, R., Zhu, L. J., Clark, J. L., Brehm, M. A., & Mercurio, A. M. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113347 · Cited by 21
Leto, S. M., Grassi, E., Avolio, M., Vurchio, V., Cottino, F., Ferri, M., Zanella, E. R., Borgato, S., Corti, G., di Blasio, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51909-2 · Cited by 20
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Li, F., Mou, M., Xiao-yi, L., Xu, W., Yin, J., Zhang, Y., & Zhu, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae791 · Cited by 20
Skarne, N., D’Souza, R. C. J., Palethorpe, H. M., Bradbrook, K. A., Gomez, G. A., & Day, B. W. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01928-x · Cited by 20
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
Paul, C. D., Yankaskas, C., Thakuri, P. S., Balhouse, B. N., Salen, S., Bullock, A., Beam, S., Chatman, A., Djikeng, S., Yang, X. J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-86979-9 · Cited by 19
Zebrafish Avatar testing preclinical study predicts chemotherapy response in breast cancer
Mendes, R. V., Ribeiro, J., Gouveia, H. S., de Almeida, C. R., Castillo-Martín, M., Brito, M. J., Canas‐Marques, R., Batista, E., Alves, C., Sousa, B., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00882-0 · Cited by 19
Harnessing Organoid Platforms for Nanoparticle Drug Development
Chen, L., Luo, X., Zhang, J., Zhang, J., Yang, C., & Zhao, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530999 · Cited by 19
Self-citationXuan, Q. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1664645 · Cited by 22
Hermida‐Prado, F., Xie, Y., Sherman, S., Nagy, Z., Russo, D., Akhshi, T. K., Chu, Z., Feit, A. S., Campisi, M., Chen, M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1711 · Cited by 19
Self-citationChang, K.-C., Silvestri, F., Oliphant, M. U. J., Martinez-Gakidis, M. A., Orgill, D. P., Garber, J. E., Dillon, D. A. R., & Brugge, J. S. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00714-7 · Cited by 18
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
Pettersen, S., Øy, G. F., Egeland, E. V., Juell, S., Engebråten, O., Mælandsmo, G. M., & Prasmickaite, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1040665 · Cited by 18
Peterson, J. R., Cole, J. A., Pfeiffer, J. R., Norris, G. H., Zhang, Y., Lopez-Ramos, D., Pandey, T., Biancalana, M., Esslinger, H. R., Antony, A. K., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01654-z · Cited by 18
Oliphant, M. U. J., Akshinthala, D., & Muthuswamy, S. K. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01798-6 · Cited by 18
Blawski, R., Vokshi, B., Guo, X., Kittane, S., Sallaku, M., Chen, W., Gjyzari, M., Cheung, T., Zhang, Y., Simpkins, C. E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114174 · Cited by 19
Yamamoto, V. N., Wang, B., & Lee, A. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1044699 · Cited by 17
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer
der Maur, P. A., Trefny, M. P., Baumann, Z., Vulin, M., Correia, A. L., Diepenbruck, M., Kramer, N., Volkmann, K., Preca, B., Ramos, P. M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101002 · Cited by 17
Breast cancer PDxO cultures for drug discovery and functional precision oncology
Scherer, S. D., Zhao, L., Butterfield, A. J., Yang, C., Cortes-Sanchez, E., Guillen, K. P., Welm, B. E., & Welm, A. L. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102402 · Cited by 17
Self-citationUematsu, H., Saito, C., Kondo, J., Onuma, K., Coppo, R., Mori, Y., Muto, M., Kikawa, Y., Tada, M., Sugie, T., et al. (2023) · Human Cell · doi:10.1007/s13577-023-00975-7 · Cited by 18
Jiao, F., Yu, C., Wheat, A. J., Chen, L., Lih, T. M., Zhang, H., & Huang, L. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00832 · Cited by 17
Mediratta, K., El‐Sahli, S., Marotel, M., Awan, M. Z., Kirkby, M., Salkini, A., Kurdieh, R., Abdisalam, S., Shrestha, A., Censo, C. D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1366197 · Cited by 17
Organoid Models for Cancer Research—From Bed to Bench Side and Back
Kastner, C., Hendricks, A., Deinlein, H., Hankir, M. K., Germer, C., Schmidt, S., & Wiegering, A. (2021) · Cancers · doi:10.3390/cancers13194812 · Cited by 18
Petrosyan, V., Dobrolecki, L. E., LaPlante, E. L., Srinivasan, R. R., Bailey, M. H., Welm, A. L., Welm, B. E., Lewis, M. T., & Milosavljevic, A. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00476-0 · Cited by 17
Self-citationThe challenge of making the right choice: patient avatars in the era of cancer immunotherapies
Kayser, C., Bräuer, A., Susanne, S., & Wandmacher, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237565 · Cited by 17
Kumar, A., Goel, H. L., Silva, C. A., Wang, T., Geng, Y., Wang, M., Goel, S., Hu, K., Li, R., Zhu, L. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181368 · Cited by 16
Jin, J., Chen, W., Li, J., Yang, J., Dai, R., Tang, J., Li, M., Chen, Y., Zhang, C., & Liu, J. (2025) · Biofabrication · doi:10.1088/1758-5090/adf099 · Cited by 16
Ringnalda, F. C. A. S., van Son, G. J. F., Verweij, L. H. G., Kim, S., Amo-Addae, V., Flucke, U. E., Hiemcke‐Jiwa, L. S., Langenberg, K. P. S., Bramer, J. A. M., Heimans, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62673-2 · Cited by 20
Advances in Tumor Organoids for the Evaluation of Drugs: A Bibliographic Review
Londoño-Berrío, M., Castro, C. I., Cañas, A. I., Ortiz, I., & Osorio, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122709 · Cited by 16
Fidelito, G., Souza, D. P. D., Niranjan, B., Nardo, W. D., Keerthikumar, S., Brown, K., Taylor, R. A., & Watt, M. J. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0796 · Cited by 16
Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer
Surina, Tanggis, Suzuki, T., Hisata, S., Fujita, K., Fujiwara, S., Liu, F., Fukushima, N., Suzuki, T., Mato, N., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13829 · Cited by 16
The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Psilopatis, I., Mantzari, A., Vrettou, K., & Theocharis, S. E. (2023) · Biomedicines · doi:10.3390/biomedicines11030773 · Cited by 16
Shan, P., Wang, C., Chen, H., Yu, J., & Zhang, H. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106741 · Cited by 19
Egeland, E. V., Seip, K., Skourti, E., Øy, G. F., Pettersen, S., Pandya, A. D., Dahle, M. A., Haugen, M. H., Kristian, A., Nakken, S., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02875-5 · Cited by 17
Engineering high throughput screening platforms of cervical cancer
Cadena, I., Buchanan, M. R., Harris, C. G., Jenne, M., Rochefort, W. E., Nelson, D., & Fogg, K. C. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37522 · Cited by 16
Intersection of ferroptosis and nanomaterials brings benefits to breast cancer
Gao, J., Ma, N., Ni, S., & Han, X. F. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10067-x · Cited by 17
Pal, P., Millner, A., Semina, S. E., Huggins, R. J., Running, L. S., Aga, D. S., Tonetti, D. A., Schiff, R., Greene, G. L., Atilla‐Gokcumen, G. E., et al. (2022) · Cancers · doi:10.3390/cancers14102380 · Cited by 16
Malik, N., Kim, Y., Yan, H., Tseng, Y., du Bois, W., Ayaz, G., Tran, A. D., Ramírez, L. V., Yang, H. H., Michalowski, A. M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2525 · Cited by 16
Lin, Y., Gao, H., Li, H., Hu, Q., Du, B., Li, S., Xu, F., Cheng, M., Zou, J., Zheng, X., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34945 · Cited by 15
Advances of Patient-Derived Organoids in Personalized Radiotherapy
Wang, Y., Li, Y., Sheng, Z., Deng, W., Yuan, H., Wang, S., & Liu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888416 · Cited by 19
Bullock, E., Rozyczko, A., Shabbir, S., Tsoupi, I., Young, A. I. J., Trávníčková, J., Gómez-Cuadrado, L., Mabruk, Z., Carrasco, G., Morrow, E. S., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02074-x · Cited by 17
Tan, D., An, J., Gong, M., Wang, H. H., Li, H., Han, M., Zhang, C., Zhao, Y., Xu, G., & Shi, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1043479 · Cited by 15
Establishment and Culture of Patient-Derived Breast Organoids
Aggarwal, D., Russo, S., Naik, P. K., Bhatia, S., & Spector, D. L. (2023) · Journal of Visualized Experiments · doi:10.3791/64889 · Cited by 15
Zhang, W., & Zheng, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122322 · Cited by 15
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Lamichhane, A., & Tavana, H. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00798-y · Cited by 16
Musiani, D., Yücel, H., Vallette, M., Angrisani, A., Botty, R. E., Ouine, B., Schintu, N., Adams, C., Chevalier, M., Derrien, H., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.01.031 · Cited by 14
Kim, S., Son, E., Park, H.-R., Kim, M., & Yang, H. W. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188839 · Cited by 14
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
Gou, X., Kim, B.-J., Anurag, M., Lei, J. T., Young, M. N., Holt, M. V., Fandino, D. M., Vollert, C. T., Singh, P., Alzubi, M. A., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3484 · Cited by 14
Self-citationKumari, R., Xu, X., & Li, H. (2022) · Current Protocols · doi:10.1002/cpz1.431 · Cited by 13
Preclinical models for development of immune–oncology therapies
Wang, Y., Shelton, S. E., Kastrunes, G. M., Barbie, D. A., Freeman, G. J., & Marasco, W. A. (2022) · Immuno Oncology Insights · doi:10.18609/ioi.2022.41 · Cited by 14
Zhang, Y., Lu, A., Zhuang, Z., Zhang, S., Liu, S., Chen, H., Yang, X., & Wang, Z. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s424737 · Cited by 14
Single-Cell Transcription Mapping of Murine and Human Mammary Organoids Responses to Female Hormones
Ortiz, J. R., Lewis, S. M., Ciccone, M. F., Chatterjee, D., Henry, S., Siepel, A. C., & dos Santos, C. O. (2024) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09553-x · Cited by 13
Big data in breast cancer: Towards precision treatment
Zhang, H., Hussin, H., Hoh, C.-C., Cheong, S.-H., Lee, W.-K., & Yahaya, B. H. (2024) · Digital Health · doi:10.1177/20552076241293695 · Cited by 13
Chen, S., Shen, C., Li, W., Fan, Y., Yang, D., Wang, Y., Feng, R., Li, G., & Zhong, Z. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.118042 · Cited by 13
Santamaria‐Martínez, A., Epiney, J., Srivastava, D., Tavernari, D., Varrone, M., Milowich, D., Letovanec, I., Krueger, T., Durán, R., Ciriello, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55098-w · Cited by 14
Ryu, S., Kim, H. S., Lee, S., Yoon, S.-H., Baek, M., Park, A. Y., Lee, H., Kim, G. Y., Park, K., Jung, J.-J., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02063-0 · Cited by 13
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment
Donahue, K., Xie, H., Li, M., Gao, A., Ma, M., Wang, Y., Tipton, A. R., Semanik, N., Primeau, T. M., Li, S., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102700 · Cited by 13
Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors
Ma, M., Liu, F., Miles, H. N., Kim, E., Fields, L. G., Xu, W., & Li, L. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00154 · Cited by 13
Organoid Cultures for the Study of Mammary Biology and Breast Cancer: The Promise and ChallengesPreprint
Muthuswamy, S. K., & Brugge, J. S. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041661 · Cited by 13
Spatial -omics technologies: the new enterprise in 3D breast cancer models
Pierantoni, L., Reis, R. L., Silva‐Correia, J., Oliveira, J. M., & Heavey, S. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.07.003 · Cited by 12
Brennen, W. N., Magnen, C. L., Karkampouna, S., Anselmino, N., Bock, N., Choo, N., Clark, A. K., Coleman, I. M., Dolgos, R., Ferguson, A. M., et al. (2024) · The Prostate · doi:10.1002/pros.24682 · Cited by 12
Advances in Organoid Technology: A Focus on Corneal Limbal Organoids
Lu, C., & Le, Q. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10706-6 · Cited by 12
Sanchez, W. L., Linder, L., Miller, R. C., Hood, A. J., & Gross, M. S. (2024) · Blockchain in Healthcare Today · doi:10.30953/bhty.v7.303 · Cited by 12
Chaudhary, N., Ferlita, A. L., Choudhary, B. S., Jog, E., Kazi, M. K., Yahya, S., Dalwai, A., Ostwal, V. S., Singh, S. V., Redkar, S., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2329 · Cited by 12
Li, Z., Peluffo, G., Stevens, L. E., Qiu, X., Seehawer, M., Tawawalla, A., Huang, X.-Y., Egri, S. B., Raval, S., McFadden, M., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02197-z · Cited by 12
Self-citationOlsen, S. N., Anderson, B., Hatton, C., Chu, Z., Simpkins, C. E., Wen, Y., Bourgeois, W., Haarer, E. L., Brown, M. A., Jeselsohn, R. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102192 · Cited by 12
Self-citationPranav, P., Palaniyandi, T., Baskar, G., Ravi, M., Rajendran, B. K., Sivaji, A., & Ranganathan, M. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151910 · Cited by 12
Application of nanomaterials in organoid culture and cryopreservation
He, W. J., Sun, Q., Ge, D., Liu, Y., & Sun, B. (2025) · Nanoscale Advances · doi:10.1039/d5na00534e · Cited by 11
Chen, D., Li, Y., Liu, X., Zhao, Y., Ren, T., Guo, J., Yang, D., & Li, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c15432 · Cited by 11
Saleh, R. O., Ibrahim, F. M., Pallathadka, H., Kaur, I., Ahmad, I. S., Ali, S. H. J., Redhee, A. H., Ghildiyal, P., Jawad, M. A., & Alsaadi, S. B. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3992 · Cited by 11
Exploring tumor organoids for cancer treatment
Jin, H., Yang, Q., Yang, J., Wang, F., Feng, J., Lei, L., & Dai, M. (2024) · APL Materials · doi:10.1063/5.0216185 · Cited by 11
Application and prospect of organoid technology in breast cancer
Huang, S., Mei, Z., Wan, A., Zhao, M., & Qi, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1413858 · Cited by 11
Chica-Parrado, M. D. R., Kim, G. M., Uemoto, Y., Napolitano, F., Lin, C.-C. A., Ye, D., Bikorimana, E., Fang, Y. V., Lee, K., Mendiratta, S., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217219 · Cited by 11
Wang, Z.-J., Zhan, X.-Y., Ma, L.-Y., Yao, K., Dai, H.-Y., Santhanam, R. K., Zhou, M.-S., & Jia, H. M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116577 · Cited by 11
Zhou, S., Zhang, Y., Belmar, J., Hou, C., Zhang, Y., Peng, C., Meng, Y., Li, Z., Jameel, M., Gao, Y., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2492 · Cited by 11
Self-citationRouault, C. D., Bansard, L., Martínez‐Balsalobre, E., Bonnet, C., Wicinski, J., Lin, S., Colombeau, L., Debieu, S., Pinna, G., Vandamme, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57476-4 · Cited by 11
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
Gao, Y., Julio, M. K., Peng, R., & Dorn, P. (2022) · Cancers · doi:10.3390/cancers14153758 · Cited by 12
Emerging target discovery and drug repurposing opportunities in chordoma
Freed, D. M., Sommer, J., & Punturi, N. B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1009193 · Cited by 11
Wan, Y., Ding, J., Jia, Z., Hong, Y., Tian, G., Zheng, S., Pan, P., Wang, J., & Liang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32965 · Cited by 13
Katmerlikaya, T. G., Dağ, A., Özgen, P. S. O., & Ersen, B. Ç. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00749 · Cited by 11
The Power and Promise of Patient-Derived Xenografts of Human Breast CancerPreprint
Lewis, M. T., & Caldas, C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041329 · Cited by 11
Self-citationZhang, K., Zhu, H., Sun, Q., Yang, J., Zhao, G., Wei, Q., Lin, M., Cao, Y., & Bian, L. (2025) · Materials Today · doi:10.1016/j.mattod.2025.08.020 · Cited by 10
Wawruszak, A., Okoń, E., & Dudziak, K. (2023) · Medical Science Monitor · doi:10.12659/msm.940550 · Cited by 12
Leveraging preclinical models of metastatic breast cancer
Pedroza, D. A., Gao, Y., Zhang, X. H.-F., & Rosen, J. M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189163 · Cited by 11
Liposomes and Their Therapeutic Applications in Enhancing Psoriasis and Breast Cancer Treatments
Elkordy, A., Hill, D. S., Attia, M., & Chaw, C. S. (2024) · Nanomaterials · doi:10.3390/nano14211760 · Cited by 10
Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2
Sui, Z., Wu, X., Wang, J., Tan, S., Zhao, C., Yu, Z., Wu, C., Wang, X., & Guo, L. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04128-x · Cited by 10
Ciringione, A., & Rizzi, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104572 · Cited by 10
Yang, J., Yang, Y., Xu, P., Yao, Y., Tian, H., Wang, X., Fang, H., Ge, S., Yao, Y., Wang, Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002530 · Cited by 10
Single‐cell transcriptional atlas of human breast cancers and model systems
Altman, J. E., Olex, A. L., Zboril, E. K., Walker, C. J., Boyd, D. C., Myrick, R. K., Hairr, N. S., Koblinski, J. E., Puchalapalli, M., Hu, B., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70044 · Cited by 11
Shea, A., Lubling, Y., Guerrero-Romero, D., García, R. M., Greenwood, W., O’Reilly, M., Georgopoulou, D., Callari, M., Lerda, G., Wix, S., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1703 · Cited by 9
TRIM24 as a therapeutic target in endocrine treatment–resistant breast cancer
Padrão, N., Gregoricchio, S., Eickhoff, N., Dong, J., Luzietti, L., Bossi, D., Severson, T., Siefert, J. C., Calcinotto, A., Buluwela, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507571122 · Cited by 9
Hendriks, H. R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189467 · Cited by 11
Jeong, W., Kim, D., Wajih, N., Kang, H., Howard-McNatt, M. M., Votanopoulos, K. I., Söker, S., & Lee, S. J. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.12.026 · Cited by 9
Xing, F., Ai, N., Huang, S., Jiang, C., Jameel, M., Ge, W., Wang, G., & Deng, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.839078 · Cited by 9
Self-citationVaklavas, C., Matsen, C. B., Chu, Z., Boucher, K. M., Scherer, S. D., Pathi, S. S., Beck, A. C., Brownson, K. E., Buys, S. S., Chittoria, N., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00724 · Cited by 9
Self-citationPrecision medicine for breast cancer: advances and challenges
Liu, X., Yu, T., & Shao, Z.-M. (2024) · Translational Breast Cancer Research · doi:10.21037/tbcr-24-35 · Cited by 9
Xu, X., Gao, Y., Dai, J., Wang, Q., Wang, Z., Liang, W., Zhang, Q., Ma, W., Liu, Z., Luo, H., et al. (2024) · Small Methods · doi:10.1002/smtd.202400204 · Cited by 8
Uemoto, Y., Lin, C.-C. A., Wang, B., Ye, D., Fang, Y. V., Bikorimana, E., Napolitano, F., Chica-Parrado, M. D. R., Li, C. I., Mendiratta, S., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217668 · Cited by 9
Resistance to neoadjuvant chemotherapy in breast cancers: a metabolic perspective
Desgres, M., Poyraz, M., Sari, B., Duhoux, F. P., van Marcke, C., & Corbet, C. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03500-w · Cited by 8
Animal models in preclinical evaluation of CAR-T cell therapy: Advantages and limitations
Fløe, L. V. B., Pedersen, M. G., & Møller, B. K. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189455 · Cited by 9
Nikeghbal, P., Zamanian, D., Burke, D., & Steinkamp, M. P. (2025) · BMC Cancer · doi:10.1186/s12885-025-14811-8 · Cited by 9
Preclinical models of breast cancer metastasis: strengths, limitations, and clinical relevance
Aouad, P., Halabi, K., Hayar, B., Sflomos, G., Brisken, C., Metcalfe, C., & Darwiche, N. (2026) · npj Breast Cancer · doi:10.1038/s41523-026-00928-x · Cited by 8
Metadata
- Authors
- Guillen, K. P., Fujita, M., Butterfield, A. J., Scherer, S. D., Bailey, M. H., Chu, Z., DeRose, Y. S., Zhao, L., Cortes-Sanchez, E., Yang, C.-H., Toner, J., Wang, G., Qiao, Y., Huang, X., Greenland, J. A., Vahrenkamp, J. M., Lum, D. H., Factor, R. E., Nelson, E. W., Matsen, C. B., Poretta, J. M., Rosenthal, R., Beck, A. C., Buys, S. S., Vaklavas, C., Ward, J. H., Jensen, R. L., Jones, K. B., Li, Z., Oesterreich, S., Dobrolecki, L. E., Pathi, S. S., Woo, X. Y., Berrett, K. C., Wadsworth, M. E., Chuang, J. H., Lewis, M. T., Marth, G. T., Gertz, J., Varley, K. E., Welm, B. E., & Welm, A. L.
- Affiliations
- University of Utah (US)
- Huntsman Cancer Institute (US)
- University of Pittsburgh (US)
- Baylor College of Medicine (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Corresponding author
- Welm, Bryan E.
- Welm, Alana L.
- ORCID
- Fujita, Maihi
- Scherer, Sandra D.
- Bailey, Matthew H.
- Chu, Zhengtao
- Zhao, Ling
- Cortes-Sanchez, Emilio
- Huang, Xiaomeng
- Vahrenkamp, Jeffery M.
- Lum, David H.
- Factor, Rachel E.
- Nelson, Edward W.
- Matsen, Cindy B.
- Beck, Anna C.
- Buys, Saundra S.
- Vaklavas, Christos
- Ward, John H.
- Jensen, Randy L.
- Jones, Kevin B.
- Li, Zheqi
- Oesterreich, Steffi
- Dobrolecki, Lacey E.
- Woo, Xing Yi
- Berrett, Kristofer C.
- Wadsworth, Mark E.
- Chuang, Jeffrey H.
- Lewis, Michael T.
- Gertz, Jason
- Varley, Katherine E.
- Welm, Bryan E.
- Welm, Alana L.
- Venue
- Nature Cancer
- Published
- 2022-02-24
- Volume
- 3
- Issue
- 2
- Pages
- 232-250
- ISSN
- 2662-1347 (ISSN-L)
- PMC
- PMC8882468
- OpenAlex
- W4214507610
- Cited by
- 416
- References
- 69
- Citations by year
- 2026: 87 · 2025: 99 · 2024: 104 · 2023: 78 · 2022: 43
- FWCI
- 33.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- U.S. Department of Defense (W81XWH1210077, W81XWH1410417)
- American Cancer Society (P30 CA042014)
- Breast Cancer Research Foundation
- Cancer Prevention and Research Institute of Texas (CA125123, RP170691)
- University of Utah (P30 CA042014)
- Huntsman Cancer Foundation (P30CA042014)
- Huntsman Cancer Institute (P30CA042014)
- National Institutes of Health (/ NCI R01, CA125123)
- National Human Genome Research Institute (T32HG008962)
- National Cancer Institute (R01CA221303, NCI-CA125123, CA125123, U01CA217617, U54CA224076, U24CA224067, P30CA042014, P30CA125123)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- breast cancer, patient-derived xenografts, organoids, endocrine-resistant breast cancer, metastatic breast cancer, triple-negative breast cancer, precision oncology, drug screening, drug repurposing, treatment-refractory cancer
- MeSH terms
- Humans, Organoids, United States, Xenograft Model Antitumor Assays, Drug Discovery, Precision Medicine, Heterografts, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
